Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 14:4:48.
doi: 10.3389/fmicb.2013.00048. eCollection 2013.

"Stormy waters ahead": global emergence of carbapenemases

Affiliations

"Stormy waters ahead": global emergence of carbapenemases

Gopi Patel et al. Front Microbiol. .

Abstract

Carbapenems, once considered the last line of defense against of serious infections with Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem-resistant Gram-negative pathogens is forcing practitioners to rely on uncertain alternatives. As little as 5 years ago, reports of carbapenem resistance in Enterobacteriaceae, common causes of both community and healthcare-associated infections, were sporadic and primarily limited to case reports, tertiary care centers, intensive care units, and outbreak settings. Carbapenem resistance mediated by β-lactamases, or carbapenemases, has become widespread and with the paucity of reliable antimicrobials available or in development, international focus has shifted to early detection and infection control. However, as reports of Klebsiella pneumoniae carbapenemases, New Delhi metallo-β-lactamase-1, and more recently OXA-48 (oxacillinase-48) become more common and with the conveniences of travel, the assumption that infections with highly resistant Gram-negative pathogens are limited to the infirmed and the heavily antibiotic and healthcare exposed are quickly being dispelled. Herein, we provide a status report describing the increasing challenges clinicians are facing and forecast the "stormy waters" ahead.

Keywords: CHDL; KPC; NDM-1; OXA-48; carbapenemases; metallo-β-lactamases.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
FIGURE 1. Basic genetic construct of select carbapenemase genes. (A) Schematic representation of Tn4401 type of transposon associated with blaKPC which includes a transposase gene (tnpA), a resolvase gene (tnpR), as well as insertion sequences, ISKpn6 and ISKpn7 (Cuzon et al., 2010). (B) The blaNDM-1 construct demonstrates ISAba125 insertion sequence(s) upstream of the blaNDM-1 and a novel bleomycin resistance gene, bleMBL, downstream (Dortet et al., 2012). (C) blaOXA-48 is often mapped to a Tn1999 composite transposon where it is bracketed between two copies of the same insertion sequence, IS1999. Downstream of blaOXA-48 lies a lysR gene which encodes for a regulatory protein (Poirel et al., 2012b).

References

    1. Abdelaziz M. O., Bonura C., Aleo A., El-Domany R. A., Fasciana T., Mammina C. (2012). OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010. J. Clin. Microbiol. 50 2489–2491 - PMC - PubMed
    1. Acosta J., Merino M., Viedma E., Poza M., Sanz F., Otero J. R., et al. (2011). Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg. Infect. Dis. 17 1064–1067 - PMC - PubMed
    1. Adams-Haduch J. M., Onuoha E. O., Bogdanovich T., Tian G. B., Marschall J., Urban C. M., et al. (2011). Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 49 3849–3854 - PMC - PubMed
    1. Adler A., Shklyar M., Schwaber M. J., Navon-Venezia S., Dhaher Y., Edgar R., et al. (2011). Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. J. Antimicrob. Chemother. 66 2763–2766 - PubMed
    1. Afzal-Shah M., Woodford N., Livermore D. M. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45 583–588 - PMC - PubMed